XNAS
GYRO
Market cap18mUSD
Jul 10, Last price
8.51USD
1D
0.00%
1Q
9.81%
Jan 2017
-53.32%
IPO
-72.03%
Name
Gyrodyne LLC
Chart & Performance
Profile
Gyrodyne, LLC. owns, leases and manages diverse commercial properties. The firm is distinguished by its service-oriented philosophy toward property ownership and management. Gyrodyne has grown from a largely Long Island player during the past into a diversified East Coast presence with an emphasis on medical office product.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | 9,760 | |||||||||
Deferred revenue | 38 | 39 | ||||||||
Other long-term liabilities | 24,043,068,000 | (38) | ||||||||
Net debt | (3,492,692,000) | (3,493) | 5,677 | |||||||
Cash flow | ||||||||||
Cash from operating activities | 1,445,487 | |||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | (13,504) | 4,051 | ||||||||
Balance | ||||||||||
Cash | 3,492,692,000 | 3,493 | 4,083 | |||||||
Long term investments | ||||||||||
Excess cash | 3,492,692,000 | 3,493 | 4,083 | |||||||
Stockholders' equity | ||||||||||
Invested Capital | 54,764,102,000 | 26,684 | 9,799 | |||||||
ROIC | ||||||||||
ROCE | ||||||||||
EV | ||||||||||
Common stock shares outstanding | 1,483 | 1,483 | ||||||||
Price | 9.02 | 10.00 23.46% | 8.10 -29.57% | |||||||
Market cap | 14,827 23.46% | 12,010 -29.57% | ||||||||
EV | 11,334 | 17,687 | ||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT |